INTRODUCTION
============

International consensus guidelines^[@b1-kjim-17-3-174-4]--[@b3-kjim-17-3-174-4])^ have recommended measurements of the forced expiratory volume in one second (FEV~1~) or peak expiratory flow (PEFR) to assess the severity of airflow obstruction. Although the FEV~1~ is the single best measure for assessing the severity of airflow obstruction, the PEFR is a simple, reproducible measure that correlates well with the FEV~1~^[@b1-kjim-17-3-174-4])^. And spirometry is a measurement that is not available to the majority of physicians treating patients with asthma. Therefore, the British guideline^[@b4-kjim-17-3-174-4])^ concentrates on PEFR, giving a chart of predicted normal values, and the international guidelines^[@b1-kjim-17-3-174-4]--[@b3-kjim-17-3-174-4])^ suggest that PEFR is an alternative to FEV~1~ when expressed as % of predicted normal values.

However, several investigators^[@b5-kjim-17-3-174-4]--[@b7-kjim-17-3-174-4])^ have demonstrated that there is a considerable disagreement between FEV~1~ and PEFR in estimating the degree of airway obstruction. FEV~1~ provides an integrated measurement of airflow from both large and peripheral airways and PEFR is a measure of large airways function^[@b8-kjim-17-3-174-4])^. The obstructive lung diseases, such as asthma and emphysema, usually show an 'airway collapse' type of the maximal expiratory flow volume curve, resulting in an FEV~1~ disproportionately lower than PEFR^[@b9-kjim-17-3-174-4])^. In addition, it is known that when an asthma attack resolves, the airways obstruction reverses first in the large airways and then in the more peripheral airways^[@b10-kjim-17-3-174-4])^. Since FEV~1~ and PEFR values are not equivalent, Sawyer et al.^[@b7-kjim-17-3-174-4])^ suggested that the published guidelines should avoid the assumption of parity between the two measurements. Although Sawyer et al.^[@b7-kjim-17-3-174-4])^ demonstrated the non-equivalence very well, they did not discriminate inter-instrumental variation from intrinsic difference of the two measurements. And, as far as we know, there is still no study reporting any difference between FEV~1~ and PEFR obtained with PEFR meter sequentially following a commencement of therapy in acute asthma.

This study demonstrates a marked difference between FEV~1~ and PEFR in sequential manner during acute asthma treatment and discloses the relative roles of the possible factors contributing to the difference.

MATERIALS and METHODS
=====================

The study subjects consisted of 35 consecutive patients (18 females, 17 males; mean age 51.7 years, range 22--73) who visited the emergency room (ER) of Chonnam National University Hospital, Gwangju, Korea (the altitude: 70 m) due to acute severe asthma over approximately a four-month period. FEV~1~ and PEFR were measured on presentation, one hour after initial treatment, and 1, 3, 5, 7 days later. FEV~1~ and PEFR were measured by using a Fleisch pneumotachograph (Spiro Analyzer ST-250; Fukuda Sangyo, Tokyo, Japan), and a PEFR was additionally measured with a Ferraris PEFR meter (Pocketpeak^®^ peak flow meter; Ferraris Medical, Inc., CA, USA). Each patient performed the tests with techniques that meet standards developed by the American Thoracic Society (ATS)^[@b11-kjim-17-3-174-4])^. All the patients showed a reduced ratio of FEV~1~/FVC (\<65%) indicating airflow obstruction.

The severity of airflow obstruction was evaluated by comparison of the patient's results with the predicted values for FEV~1~ developed by Crapo et al.^[@b12-kjim-17-3-174-4])^ and for spirometric PEFR by Knudson et al.^[@b13-kjim-17-3-174-4])^ because the instruction manual for spirometry provided by the manufacturer of the spirometer denotes them as the predictive equations recommended by the Intermountain Thoracic Society. In accordance with the recommendation by the manufacturer of Ferraris PEFR meter, we used the predictive equations developed by Leiner et al.^[@b14-kjim-17-3-174-4])^. For secondary analyses, measurements of FEV~1~ were expressed as a % of predicted values, using predictive equations developed by Knudson et al.^[@b13-kjim-17-3-174-4])^ and Kim et al.^[@b15-kjim-17-3-174-4])^ and PEFR by Nunn & Gregg^[@b16-kjim-17-3-174-4])^ and Kim et al.^[@b17-kjim-17-3-174-4])^. The mean differences and the 'limits of agreement' in the paired measurements of FEV~1~ and PEFR were calculated. The 'limits of agreement' (mean±standard deviation×1.96) were calculated using the methods of Bland and Altman^[@b18-kjim-17-3-174-4])^.

The international guidelines^[@b1-kjim-17-3-174-4],[@b3-kjim-17-3-174-4])^ state that severity of asthma exacerbation is classified on the basis of FEV~1~ or PEFR measurements of \>80%, 50--80%, \<50% of predicted or personal best values and the British guideline^[@b4-kjim-17-3-174-4])^ defines a PEFR \<33% of predicted or best as life-threatening attack of asthma. Therefore, the severity of airflow obstruction was classified as mild, moderate, severe and life threatening when the FEV~1~ or PEFR is \>80%, 50--80%, 33--50%, and \<33% of predicted values in this study.

Data were expressed as mean±SEM. Comparisons of the measurements between FEV~1~ and PEFR at each time point were made using the Student's *t*-test for paired values. Pearson's correlation was used to examine the relationships between FEV~1~ and PEFR. And comparisons of asthma severity between FEV~1~ and PEFR were made by using Wilcoxon matched-pair signed-ranks test and McNemar test. A probability value of less than 0.05 was considered statistically significant.

RESULTS
=======

On ER presentation, all patients could get PEFR values by using the Ferraris PEFR meter (f-PEFR), but 4 patients' airflow obstructions were so severe as to prevent performance of a forced vital capacity (FVC) maneuver to get FEV~1~. There was a significant relationship between the 179-paired measurements of FEV~1~ and f-PEFR expressed as % predicted values (r=0.719, *p*\<0.001). However, there was a considerable skew in distribution of measurements toward the PEFR axis ([Figure 1](#f1-kjim-17-3-174-4){ref-type="fig"}).

And the mean values (±SEM) of measurements expressed as % predicted were significantly higher in f-PEFR than those in FEV~1~ at each time point (46.4±3.3% vs. 35.9±2.6% at 0, 56.1±4.4% vs. 43.5±3.4% at 1 hour, 64.9±4.1% vs. 48.1±3.5% at 1 day, 70.6±4.9% vs. 51.2±3.7% at 3 day, 76.2±4.5% vs. 56.7±3.9% at 5 day, 79.3±5.0% vs. 62.3±4.0% at 7 day, *p*\<0.01, respectively; [Figure 2](#f2-kjim-17-3-174-4){ref-type="fig"}). The mean difference of measurements in total was 16.1±1.4% between FEV~1~ and f-PEFR.

Because FEV~1~ is quite reproducible, has a relatively narrow normal range and reflects the clinical severity of the disease, it is used widely in clinical practice as the representative parameter to indicate the severity of airflow obstruction. Therefore, we considered FEV~1~ as the true value of lung function and measured the difference of f-PEFR against this true value ([Figure 3](#f3-kjim-17-3-174-4){ref-type="fig"}). The limits of agreement for f-PEFR were unacceptably wide (−20.0--52.3% in total).

The airflow obstruction on presentation was mild in 3.2%, moderate in 29.0%, severe in 58.1% and life-threatening in 9.7% of patients when f-PEFR was used for the classification of severity, while mild in 0%, moderate in 22.6%, severe in 22.6% and life-threatening in 54.8% when FEV~1~ was used, which was significantly different (*p*\<0.01). The classification differences in total were also significant (*p*\<0.001, [Table 1](#t1-kjim-17-3-174-4){ref-type="table"}).

The discrepancy was inter-instrumental in large part. The mean differences were 16.1±1.4% between FEV~1~, and f-PEFR, 10.1±1.4% between f-PEFR and spirometric PEFR (s-PEFR) and 6.0±1.4% between s-PEFR and FEV~1~ ([Table 2](#t2-kjim-17-3-174-4){ref-type="table"}). The mean values of f-PEFR were significantly higher than those of s-PEFR at each time point except 1 hour (45.3±3.8% vs. 39.0±3.3%, 57.4±5.9% vs. 50.2±4.5%, 64.6±5.6% vs. 50.9±5.7%, 74.8±6.4% vs. 65.0±5.8%, 77.0±8.2% vs. 67.0±8.0%, 85.6±9.6% vs. 75.2±8.1%; *p*\<0.05, respectively, except no significance at 1 hour). The actual values of f-PEFR were 19.2±1.6% higher than s-PEFR ([Table 2](#t2-kjim-17-3-174-4){ref-type="table"}, [Figure 4](#f4-kjim-17-3-174-4){ref-type="fig"}). The mean values of s-PEFR were not significantly different from those of FEV~1~ except *p*\<0.01 at 3 day (39.2±3.5% vs. 35.5±2.6%, 51.1±4.7% vs. 46.2±4.5%, 50.3±5.9% vs. 47.7±4.6%, 63.0±6.2% vs. 52.7±5.6%, 67.0±8.0% vs. 59.6±6.5%, 76.6±7.6% vs. 67.3±6.9%). However, the difference in the classification of severity of airflow obstruction between FEV~1~ and s-PEFR was significant in total (*p*\<0.05, [Table 1](#t1-kjim-17-3-174-4){ref-type="table"}).

The use of other predictive equations altered the degree of the differences but could not completely correct it. The Korean equations by Kim et al.^[@b15-kjim-17-3-174-4])^ for FEV~1~ and by Kim et al^[@b17-kjim-17-3-174-4])^ for PEFR gave a bigger difference (18.3±1.5%). The predicted value for FEV~1~ calculated by using the equations by Crapo et al.^[@b12-kjim-17-3-174-4])^ was higher than that by Knudson et al.^[@b13-kjim-17-3-174-4])^ and the value for PEFR by Leiner et al.^[@b14-kjim-17-3-174-4])^ lower than that by Nunn & Gregg^[@b16-kjim-17-3-174-4])^. As a consequence, the mean difference of the 179 paired measurements was biggest between f-PEFR by Leiner et al.^[@b14-kjim-17-3-174-4])^ and FEV~1~ by Crapo et al.^[@b12-kjim-17-3-174-4])^ (16.1±1.4%) and decreased to 11.2±1.4% using the equation by Knudson et al.^[@b13-kjim-17-3-174-4])^ for FEV~1~, to 10.4±1.4% by Nunn & Gregg^[@b16-kjim-17-3-174-4])^ for f-PEFR and to 5.5±1.5% by Nunn & Gregg^[@b16-kjim-17-3-174-4])^ for f-PEFR and by Knudson et al.^[@b13-kjim-17-3-174-4])^ for FEV~1~ ([Table 2](#t2-kjim-17-3-174-4){ref-type="table"}). However, the lowest difference by Nunn & Gregg^[@b16-kjim-17-3-174-4])^ for f-PEFR and by Knudson et al.^[@b13-kjim-17-3-174-4])^ for FEV~1~ also gave a significant difference in the classification of severity of airflow obstruction between FEV~1~ and f-PEFR in total (*p*\<0.01, [Table 1](#t1-kjim-17-3-174-4){ref-type="table"}). The difference from FEV~1~ was negligible (0.4±1.4%) only when PEFR was obtained with spirometry and expressed by using Knudson's equations^[@b13-kjim-17-3-174-4])^ for both ([Table 2](#t2-kjim-17-3-174-4){ref-type="table"}, [Figure 4](#f4-kjim-17-3-174-4){ref-type="fig"}).

DISCUSSION
==========

The f-PEFR correlated well with the FEV~1~ but, there was a considerable disagreement between FEV~1~ and f-PEFR is estimating the degree of airflow obstruction, which is consistent with previous studies^[@b5-kjim-17-3-174-4]--[@b7-kjim-17-3-174-4])^. Sawyer et al.^[@b7-kjim-17-3-174-4])^ demonstrated that PEFR measured using Wright PEFR meter was higher than spirometric FEV~1~, with a mean difference of 17.2% which is consistent with our mean difference of 16.1% and suggested that the current international consensus guidelines should be revised to indicate that measurements of FEV~1~ and PEFR are not equivalent when expressed as % predicted values.

The wide limits of agreement (−20.0--52.3%) were not acceptable because ATS^[@b11-kjim-17-3-174-4])^ recommends that the instrument must measure PEFR within an accuracy of ±10% of reading or ±18 L/min, whichever is greater. Assessment of severity of airflow obstruction was significantly different between both measurements, which is consistent with the results by Sawyer et al.^[@b7-kjim-17-3-174-4])^. Because the international guidelines^[@b1-kjim-17-3-174-4]--[@b4-kjim-17-3-174-4])^ state that the intensity of treatment should tailor to the severity of the exacerbation, many patients with acute asthma may receive an undertreatment if their exacerbations are judged only on PEFR values.

The EPR2^[@b3-kjim-17-3-174-4])^ emphasizes that PEFR meters are designed as tools for ongoing monitoring, not diagnosis. At any time, there is a question about the validity of PEFR meter reading and PEFR values from the portable PEFR meter and from laboratory spirometry should be compared. Although the statements admit the fact that the PEFR measurements may be inaccurate, the EPR2^[@b3-kjim-17-3-174-4])^ still states the asthma severity to be classified based on FEV~1~ or PEFR measurement. This study reconfirms the actual difference between FEV~1~ and PEFR measurements and arouses the necessity for the validity evaluation when PEFR is used for assessing severity of airflow obstruction in acute asthma.

In this study, the differences were primarily derived from the uses of different measuring instruments. PEFR measured with the Ferraris PEFR meter was 19.2% higher than that with the spirometer, which is consistent with the report by Miller et al.^[@b19-kjim-17-3-174-4])^ showing that the PEFR measurement with a Ferraris PEFR meter is higher up to 80 L/min than that with a Fleisch pneumotachograph at 360 L/min. Therefore, the measurements must be converted to % predicted values using the predictive equations suitable for each instrument to reduce this problem, and the difference could be reduced to about half (to 10.1%) by using the predictive equations developed by Leiner et al.^[@b14-kjim-17-3-174-4])^ for f-PEFR in accordance with the manufacturer's recommendation in this study. Unfortunately, the Leiner equations were made by using a Wright PEFR meter and so the values converted with the Leiner equations in this study may still over read as Miller et al.^[@b19-kjim-17-3-174-4])^ demonstrated that the PEFR measurement with a Ferraris PEFR meter was higher approximately 40 L/min than the PEFR measured with a Wright PEFR meter. Although it is well known that lung function depends on race, the Korean equations^[@b15-kjim-17-3-174-4],[@b17-kjim-17-3-174-4])^ could not correct the difference in this study. As another contributing factor, Wensley et al.^[@b20-kjim-17-3-174-4])^ recently showed PEFR maneuver itself causing a greater PEFR value than FVC maneuver.

European Respiratory Society^[@b21-kjim-17-3-174-4])^ states that the reference values for PEFR have substantial differences between them and PEFR reference values derived from spirometric readings should not be applied to readings from PEFR meters. The present study also showed considerable differences among the predictive equations, and f-PEFR, expressed using predictive equation by Knudson et al.^[@b13-kjim-17-3-174-4])^ which was developed for spirometric PEFR, was most markedly deviated from FEV~1~ as expected. And the lowest difference was obtained by Knudson et al.^[@b13-kjim-17-3-174-4])^ for FEV~1~ and by Nunn & Gregg^[@b16-kjim-17-3-174-4])^ for f-PEFR. However, this difference still caused a significant alteration in the classification of asthma severity, and so the different predictive equations could not completely correct the discrepancy between FEV~1~ and PEFR.

Because FEV~1~ and PEFR represent function of airway portions different form each other^[@b8-kjim-17-3-174-4])^, PEFR may underestimate severity of airflow obstruction intrinsically. Moreover, the reversal of airflow obstruction in asthma begins from the large airways^[@b10-kjim-17-3-174-4])^. In this study, the mean differences between f-PEFR and FEV~1~ were increased progressively from 10.5% on presentation to 19.5% at 5 day, which is a consistent finding with the previous observations. However, s-PEFR was not significantly different from FEV~1~ when calculated by using the equations by Kudson et al.^[@b13-kjim-17-3-174-4])^ for both, and so the intrinsic difference between FEV~1~ and PEFR was not so much apparent.

Taken together, PEFR underestimated the severity of airflow obstruction in acute asthma and the discrepancy between FEV~1~ and PEFR was inter-instrumental in large part. Different predictive equations altered the degree of the differences but could not completely correct it. Therefore, these confounding factors should be considered when the severity of airflow obstruction is assessed with PEFR.

![The relationship between FEV~1~ and f-PEFR measurements (% predicted values). The applied predicted values were by Crapo et al.^[@b12-kjim-17-3-174-4])^ for FEV~1~ and by Leiner et al.^[@b14-kjim-17-3-174-4])^ for PEFR. Line of identity is shown (dashed). Regression equation: y = 0.90x + 21.0. There was a considerable skew in distribution of measurements toward the PEFR axis.](kjim-17-3-174-4f1){#f1-kjim-17-3-174-4}

![Comparisons between FEV~1~ and f-PEFR measurements (% predicted values) at each time point after admission to emergency room in patients with acute asthma. The applied predicted values were by Crapo et al.^[@b12-kjim-17-3-174-4])^ for FEV~1~ and by Leiner et al.^[@b14-kjim-17-3-174-4])^ for PEFR. The mean values of measurements were significantly higher in f-PEFR than those in FEV~1~ at each time point. ^\*^ *p*\<0.01, ^\*\*^ *p*\<0.001](kjim-17-3-174-4f2){#f2-kjim-17-3-174-4}

![Differences between FEV~1~ and f-PEFR measurements (% predicted values) expressed against FEV~1~. The limits of agreement were defined as mean±1.96 standard deviation. The limits of agreement for f-PEFR were unacceptably wide.](kjim-17-3-174-4f3){#f3-kjim-17-3-174-4}

![Mean values of measurements. Expression as % predicted values using various predictive equations showed considerable differences among them.](kjim-17-3-174-4f4){#f4-kjim-17-3-174-4}

###### 

Differences in the classification of severity of airflow obstruction based on FEV~1~ and PEFR measurements in patients with acute asthma

                                           Severity of airflow obstruction   *p*-value                           
  ---------------------------------------- --------------------------------- ----------- ----------- ----------- ---------
  FEV~1~ (Crapo[@b12-kjim-17-3-174-4])     17 (9.5)                          68 (38.0)   49 (27.4)   45 (25.1)   \<0.001
  f-PEFR (Leiner[@b14-kjim-17-3-174-4])    39 (21.8)                         86 (48.0)   45 (25.1)   9 (5.0)     
  FEV~1~ (Knudson[@b13-kjim-17-3-174-4])   23 (12.8)                         73 (40.8)   48 (26.8)   35 (19.6)   \<0.01
  f-PEFR (Nunn[@b16-kjim-17-3-174-4])      27 (15.1)                         83 (46.4)   55 (30.7)   14 (7.8)    
  FEV~1~ (Kim[@b15-kjim-17-3-174-4])       12 (6.7)                          72 (40.2)   47 (26.3)   48 (26.8)   \<0.001
  f-PEFR (Kim[@b17-kjim-17-3-174-4])       40 (22.3)                         85 (47.5)   44 (24.6)   10 (5.6)    
  FEV~1~ (Crapo[@b12-kjim-17-3-174-4])     11 (10.3)                         38 (35.5)   27 (25.2)   31 (29.0)   \<0.05
  s-PEFR (Knudson[@b13-kjim-17-3-174-4])   20 (18.7)                         33 (30.8)   29 (27.1)   25 (23.4)   
  FEV~1~ (Knudson[@b13-kjim-17-3-174-4])   17 (15.9)                         40 (37.4)   28 (26.2)   22 (20.6)   \>0.05
  s-PEFR (Knudson[@b13-kjim-17-3-174-4])   20 (18.7)                         33 (30.8)   29 (27.1)   25 (23.4)   

Data were expressed as case number (% of total cases).

Statistical analysis was performed by Wilcoxon matched-pair signed-ranks test.

Significance (*p*-value): compared to PEFR of the following line.

###### 

Mean differences of values expressed as % predicted using different predictive equations

                                            Spirometer   PEFR meter                                              
  ----------------------------------------- ------------ ------------ --------- ---------- ---------- ---------- ----------
  Spirometer (Fleisch Pneumotachograph)                                                                          
    FEV~1~, Crapo[@b12-kjim-17-3-174-4]     4.9±0.3      6.0±1.4      1.3±0.2   10.4±1.4   16.1±1.4   17.1±1.5   25.9±1.5
    FEV~1~, Knudson[@b13-kjim-17-3-174-4]                0.4±1.4      6.2±0.2   5.5±1.5    11.2±1.4   12.2±1.6   21.1±1.5
    PEFR, Knudson[@b13-kjim-17-3-174-4]                               6.7±1.3   4.2±1.4    10.1±1.4   10.2±1.5   19.2±1.6
    FEV~1~, Kim[@b15-kjim-17-3-174-4]                                           11.6±1.4   17.3±1.4   18.3±1.5   27.2±1.5
  Ferraris PEFR meter                                                                                            
    PEFR, Nunn[@b16-kjim-17-3-174-4]                                                       5.5±0.2    6.4±0.2    15.1±0.5
    PEFR, Leiner[@b14-kjim-17-3-174-4]                                                                0.9±0.1    9.6±0.3
    PEFR, Kim[@b17-kjim-17-3-174-4]                                                                              8.8±0.3
